Opening of manufacturing expansion announced by Nitto Denko Avecia
Nitto Denko Avecia has announced the opening of their new manufacturing facility for oligonucleotide active pharmaceutical ingredients in Milford (MA, USA).
The new 20,000 square feet expansion will provide more manufacturing and office space, allowing CGMP oligonucleotide manufacturing capacity up to 1.8mol. This expansion has more than doubled the company’s total capacity at the Milford site.
Read More